Loading...
Swedencare AB (publ)
SWDCF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.84
$0.00(0.00%)
Swedencare AB (publ) (SWDCF) Financial Performance & Income Statement Overview
Review Swedencare AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.62%
↑ 8.62%
Operating Income Growth
29.91%
↑ 29.91%
Net Income Growth
68.77%
↑ 68.77%
Operating Cash Flow Growth
-19.12%
↓ 19.12%
Operating Margin
8.40%
↑ 8.40%
Gross Margin
46.15%
↑ 46.15%
Net Profit Margin
3.58%
↑ 3.58%
ROE
1.22%
↑ 1.22%
ROIC
2.30%
↑ 2.30%
Swedencare AB (publ) (SWDCF) Income Statement & Financial Overview
Review Swedencare AB (publ)'s (SWDCF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $645.50M | $665.00M | $643.60M | $630.50M |
| Cost of Revenue | $268.50M | $277.60M | $274.60M | $571.10M |
| Gross Profit | $377.00M | $387.40M | $369.00M | $59.40M |
| Gross Profit Ratio | $0.58 | $0.58 | $0.57 | $0.09 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $224.30M |
| Operating Expenses | $331.80M | $329.40M | $314.60M | $306.20M |
| Total Costs & Expenses | $600.30M | $607.00M | $589.20M | $571.10M |
| Interest Income | $4.30M | $1.50M | $1.80M | $1.70M |
| Interest Expense | $16.10M | $17.70M | $20.90M | $21.90M |
| Depreciation & Amortization | $79.10M | $81.10M | $78.20M | $79.70M |
| EBITDA | $128.60M | $140.60M | $133.90M | $140.30M |
| EBITDA Ratio | $0.20 | $0.21 | $0.21 | $0.22 |
| Operating Income | $45.20M | $58.00M | $54.40M | $59.40M |
| Operating Income Ratio | $0.07 | $0.09 | $0.08 | $0.09 |
| Other Income/Expenses (Net) | -$12.00M | -$16.20M | -$19.60M | -$20.60M |
| Income Before Tax | $33.20M | $41.80M | $34.80M | $38.80M |
| Income Before Tax Ratio | $0.05 | $0.06 | $0.05 | $0.06 |
| Income Tax Expense | $9.40M | $18.00M | $10.80M | $17.90M |
| Net Income | $23.90M | $23.80M | $24.00M | $20.90M |
| Net Income Ratio | $0.04 | $0.04 | $0.04 | $0.03 |
| EPS | $0.15 | $0.15 | $0.15 | $0.13 |
| Diluted EPS | $0.15 | $0.15 | $0.15 | $0.13 |
| Weighted Avg Shares Outstanding | $158.86M | $158.86M | $158.82M | $158.73M |
| Weighted Avg Shares Outstanding (Diluted) | $158.86M | $158.86M | $158.82M | $158.73M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan